Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2834021rdf:typepubmed:Citationlld:pubmed
pubmed-article:2834021lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C0206249lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:2834021lifeskim:mentionsumls-concept:C1533157lld:lifeskim
pubmed-article:2834021pubmed:issue1lld:pubmed
pubmed-article:2834021pubmed:dateCreated1988-5-31lld:pubmed
pubmed-article:2834021pubmed:abstractTextIt has been proposed that activation of a calcium-sensitive protease (calpain) is a crucial step in the induction of long-term potentiation (LTP). To test this hypothesis, we used chronic recording techniques to measure the effects of intraventricular infusion of leupeptin, a calpain inhibitor, on LTP in the hippocampus. Rats implanted bilaterally with stimulating electrodes in the Schaffer-commissural system and one recording electrode in the apical dendrites of field CA1 were fitted with osmotic mini-pumps delivering either leupeptin (20 mg/ml) or saline at a rate of 0.5 microliter/h into the lateral ventricle. Short bursts of high-frequency stimulation with the bursts delivered at 5/s were used to induce LTP in those animals which had stable responses for several days. Rats in the saline group (n = 11) exhibited an immediate LTP effect that remained in place over successive days of testing, while only 3 of 13 leupeptin treated animals showed evidence of LTP 24 h after high-frequency stimulation, and in only one of those was a sizeable effect recorded over several days. The average change in responses at the 24-h test point was +33% for the controls and +4% for the leupeptin group (P less than 0.01). The block of LTP induction was reversible, since high-frequency stimulation applied after disconnecting the pumps led to a robust LTP effect that lasted for several days in 6 of 7 animals tested. There were no detectable differences in baseline responses in the presence and absence of leupeptin.lld:pubmed
pubmed-article:2834021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2834021pubmed:languageenglld:pubmed
pubmed-article:2834021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2834021pubmed:citationSubsetIMlld:pubmed
pubmed-article:2834021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2834021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2834021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2834021pubmed:statusMEDLINElld:pubmed
pubmed-article:2834021pubmed:monthMarlld:pubmed
pubmed-article:2834021pubmed:issn0006-8993lld:pubmed
pubmed-article:2834021pubmed:authorpubmed-author:BaudryMMlld:pubmed
pubmed-article:2834021pubmed:authorpubmed-author:LynchGGlld:pubmed
pubmed-article:2834021pubmed:authorpubmed-author:StaubliUUlld:pubmed
pubmed-article:2834021pubmed:authorpubmed-author:LaudalO AOAlld:pubmed
pubmed-article:2834021pubmed:authorpubmed-author:ThibaultOOlld:pubmed
pubmed-article:2834021pubmed:issnTypePrintlld:pubmed
pubmed-article:2834021pubmed:day15lld:pubmed
pubmed-article:2834021pubmed:volume444lld:pubmed
pubmed-article:2834021pubmed:ownerNLMlld:pubmed
pubmed-article:2834021pubmed:authorsCompleteYlld:pubmed
pubmed-article:2834021pubmed:pagination153-8lld:pubmed
pubmed-article:2834021pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:meshHeadingpubmed-meshheading:2834021-...lld:pubmed
pubmed-article:2834021pubmed:year1988lld:pubmed
pubmed-article:2834021pubmed:articleTitleChronic administration of a thiol-proteinase inhibitor blocks long-term potentiation of synaptic responses.lld:pubmed
pubmed-article:2834021pubmed:affiliationCenter for the Neurobiology of Learning and Memory, University of California, Irvine 92717.lld:pubmed
pubmed-article:2834021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2834021pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2834021pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:2834021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2834021lld:pubmed